doi:10.3969/j.issn.1673-8640.2018.011.019

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 7

[1]	MARASINGHE E,CHACKREWARTHY S,ABEYSENA C,et al.Micronutrient status and its relationship with nutritional status in preschool children in urban Sri Lanka[J]. Asia Pac J Clin Nutr,2015,24(1):144-151.
[2]	DAS J K,SALAM R A,KUMAR R,et al.Micronutrient fortification of food and its impact on woman and child health: a systematic review[J]. Syst Rev,2013,2:67.
[3]	BERGLUND S,WESTRUP B,DOMELLÖF M,et al. Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants[J]. Pediatrics,2010,126(4):e874-e883.
[4]	覃珊,王焱,仰大贵,等. 儿童全血微量元素含量及补充现状调查[J]. 检验医学,2013,28(8):690-692.
[5]	COSENZA L,PEZZELLA V,NOCERINO R,et al.Calcium and vitamin D intakes in children: a randomized controlled trial[J]. BMC Pediatr,2013,13:86.
[6]	肖钘,何金花,黎毓光,等. 广州市番禺区儿童全血5种微量元素检测结果分析[J]. 检验医学,2013,28(9):801-804.
[7]	潘军峰,刘莹莹,张静,等. 毫州市学龄前儿童6种微量元素检测分析[J]. 检验医学与临床,2016,13(9):1250-1252.

项目	锌（mg/L）	镁（mg/L）	铁（mg/L）	钙（mg/L）	铜（mg/L）
x	4.60	39.2	432.0	64.0	0.96
s	0.77	3.1	33.2	4.3	0.13
P值	0.034	0.000	0.000	0.000	0.000
偏度	0.101	0.318	0.207	0.223	0.594
峰度	0.284	0.644	0.340	0.845	0.916

项目	锌（mg/L）	镁（mg/L）	铁（mg/L）	钙（mg/L）	铜（mg/L）
x	4.60	39.2	432.0	64.0	0.96
s	0.77	3.1	33.2	4.3	0.13
P值	0.034	0.000	0.000	0.000	0.000
偏度	0.101	0.318	0.207	0.223	0.594
峰度	0.284	0.644	0.340	0.845	0.916

组别	例数	锌（mg/L）	铁（mg/L）	镁（mg/L）	钙（mg/L）	铜（mg/L）
<1岁组	1 317	3.66±0.68	409.3±31.7	40.1±3.2	68.9±4.4	1.03±0.14
1岁组	1 548	4.07±0.64^*	421.8±31.2^*	40.2±3.5	66.1±3.8^*	1.02±0.13^*
2岁组	1 802	4.52±0.64^*#	431.3±29.8^*#	39.7±3.1^*#	65.1±3.5^*#	0.98±0.12^*#
3~5岁组	4 949	4.63±0.63^*#△	436.1±30.2^*#△	38.9±3.1^*#△	63.8±3.4^*#△	0.97±0.12^*#△
6~16岁组	5 911	4.95±0.71^*#△▲	440.0±34.0^*#△▲	39.3±3.1^*#▲	62.2±4.0^*#△▲	0.91±0.12^*#△▲
F值		1 318.207	329.023	37.053	1 042.511	490.730
P值		0.000	0.000	0.000	0.000	0.000

组别	例数	锌（mg/L）	铁（mg/L）	镁（mg/L）	钙（mg/L）	铜（mg/L）
<1岁组	1 317	3.66±0.68	409.3±31.7	40.1±3.2	68.9±4.4	1.03±0.14
1岁组	1 548	4.07±0.64^*	421.8±31.2^*	40.2±3.5	66.1±3.8^*	1.02±0.13^*
2岁组	1 802	4.52±0.64^*#	431.3±29.8^*#	39.7±3.1^*#	65.1±3.5^*#	0.98±0.12^*#
3~5岁组	4 949	4.63±0.63^*#△	436.1±30.2^*#△	38.9±3.1^*#△	63.8±3.4^*#△	0.97±0.12^*#△
6~16岁组	5 911	4.95±0.71^*#△▲	440.0±34.0^*#△▲	39.3±3.1^*#▲	62.2±4.0^*#△▲	0.91±0.12^*#△▲
F值		1 318.207	329.023	37.053	1 042.511	490.730
P值		0.000	0.000	0.000	0.000	0.000

年龄（岁）	锌（mg/L）	镁（mg/L）	铁（mg/L）	钙（mg/L）	铜（mg/L）
<1	2.90~6.40	34.1~47.1	352.3~475.1	60.6~77.6	0.80~1.36
1	3.20~6.80	33.8~47.1	359.2~480.1	58.6~73.8	0.80~1.32
2	3.30~7.00	33.9~45.8	363.7~489.1	58.2~72.0	0.78~1.25
3~5	3.50~7.30	33.6~44.6	368.0~490.1	57.4~70.8	0.77~1.23
6~16	3.70~7.70	33.2~45.6	376.6~512.5	54.0~70.3	0.70~1.17

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 7

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.